peter kolchinsky net worth peter kolchinsky net worth

Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. The foursome plans to open for guests in the late spring of 2010. . The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. Peter Kolchinsky's largest purchase order was 2,805,045 units , worth over The Voluntary Scheme for Branded Medicines Pricing and Access is the second option, and typically has lower rates and is negotiated between the government and pharmas. Recently at Dyne Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. He holds a BA from Cornell University and a PhD in Virology from Harvard University. Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Currently GuruFocus does not have mailing address information for Kolchinsky Peter. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. All Rights Reserved. These were worth $145 million and represented 2% of its portfolio. In the interim, they plan to invite, Were not in a rush, Anna explained, and want to take some time to get to know the. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. and Catherine James, EVP and General Counsel Peter Kolchinsky / Published in City Journal / February 24, 2020 "Some health economists, such as those at the Institute for Clinical and Economic Review (ICER), believe that they can tell us the right price to pay for each new medicine that the FDA approves. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. $12.54M on September 23, 2020. and Ian F Smith, Director Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $37,758,818 and over the last 9 years he sold WVE stock worth over $58,095,632. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Insider trading is most common in February, with the busiest year in 2023. The current estimated net worth of Dyne Therapeutics, Inc's Peter Kolchinsky is estimated to be about $2.88B . In this conversation. Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. This investment adviser does not provide advice to individual investors. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Dr. Kolchinsky earned his Ph.D. in virology from Harvard University and earned his bachelors degree in Biology from Cornell University. I would love for [the Blue Horse Inn] to be the kind of place that a writer just starting on a novel escapes to for hospitality and inspiration, Keri said, adding that she hopes the new business still allows her some time for her own writing. Anna is excited about introducing her dressage horse Jurist to the local network of trails. Bens wife, Keri, grew up on a red dirt road in small-town Georgia. Please note this link is one-time use only and is valid for only 24 hours. var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. In addition to The Great American Drug Deal, he is the author of The Entrepreneurs Guide to a Biotech Startup. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. The Statutory Scheme, which is governed under UK law, is one of two that companies can use. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. He currently works with the State and Local Government Practice Group of the consulting firm Accenture. As for Peter, As soon as we get the house in order, Im looking forward to some fishing. Alfredo Naj Domingos prostate cancer was spreading. Insider trading is most common in June, with the busiest year in 2022. Peter Kolchinsky's largest purchase order was 3,178,476 units , worth over Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. Eric Lefkofsky, Tempus founder and CEO (Photo by Michael Kovac/Getty Images), Christina Aguilera joins Merz Aesthetics' 'Beauty on Your Terms' campaign for Botox rival Xeomin, Hemolytic Anemia Sales Specialist, Rare Genetic Diseases, Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups, Digital therapeutics: The key to maximizing the potential of medicinal assets, What latest wave of layoffs means for biotech; Radiotherapy shortage; Delivering on mRNA's promises; and more, Harder to find homes: Latest wave of biotech layoffs could test the industry, Esperion unveils long-awaited data on cholesterol pill's ability to cut cardiovascular risk, Tempus founders build a drug discovery startup, Pathos AI, with $40M in sight, A radioactive prostate cancer therapy is a last lifeline for patients. (LogOut/ The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. He currently manages a fund that invests in healthcare and biotechnology companies. He serves as a member of the board of directors of a number of private companies. The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. Peter Kolchinsky: We need to see the difference between a true re-infection. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. More Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. Baeder explains below not only whats coming for AAM and its member generic drug companies, but also her thoughts on the Inflation Reduction Act and the new five-year FDA user fee deal. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Stock quotes provided by InterActive Data. The drug industry stands accused of charging too much. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. Past performance is a poor indicator of future performance. Right now, he is the most trending person in social media. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn Endpoints News Top biotech investor Peter Kolchinsky tees up a new SPAC 3 days after a $300M raise for radiopharmaceuticals play News Dec 9, 2020 Endpoints News RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and other similar diseases Nexus is expected to participate in substantially all investments in private companies made by RA Capital alongside its main, longstanding fund, RA Capital Healthcare Fund L.P. Shes currently earning her PhD in European History at Boston. The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. Kolchinsky Peter Net Worth 2022 and insider trades. Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. America is rightfully outraged when patients cant afford the medicines they need. This . The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. Shes currently earning her PhD in European History at Boston College. In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of $1.64B Change), You are commenting using your Twitter account. I don't believe that temperature plays a role in the spread of Covid-19. The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. But many people worry that Covid-19 will mutate and . Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. Anna and Peter discovered Woodstock through Annas participation at the GMHA dressage events. the community will feel welcome. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $46,860,585 and over the last 8 years he sold WVE stock worth over $58,095,632. Peter Kolchinsky usually trades in September, with the busiest year in 2020. Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. $3.3K . The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. Managing Partner | RA Capital Management Peter is a founder and Managing Partner at RA Capital Management, active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Your email address will not be published. When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. 2001 - Present22 years. Arab Health 2023? as vibrant from the outside as it is on the inside. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves on the boards of publicly- and privately-held life science companies. Peter has made over 5 trades of the Wave Life Sciences stock since 2018, according to the Form 4 filled with the SEC. Ben, a storyteller and football aficionado, looks forward to evenings of camaraderie with locals and inn guests. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Peter Kolchinsky owns about 1,311,247 units of Mineralys Therapeutics, Inc common stock. Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. New to Endpoints? Peter Kolchinsky usually trades in February, with the busiest year in 2023. Peter Kolchinsky is 43, he's been the Independent Director of Wave Life Sciences since 2015. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. Robert Flexon, President and CEO, The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. one-time use only and expires after 24 hours. Keri is also a writer and is currently working on a Southern gothic novel. See Peter Kolchinsky's compensation, career history, education, & memberships. So they invited their close friends Keri and Ben up for what they expected to be a reality check. The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in continuing chemotherapy treatment. Data from the new InnoLead/KPMG US Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. In addition, they want, Coming from diverse backgrounds and interests, the foursome. 2004-2023 GuruFocus.com, LLC. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. We'll e-mail you a link to set a new password. But there was a lot of adjusting to do, for everyone in the family. It was simply awesome! If you're already an Endpoints subscriber, enter your email below for a $140.3K . 2004-2023 GuruFocus.com, LLC. The group has been building an incubator with 19 projects and two startups to their credit. Save my name, email, and website in this browser for the next time I comment. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are . Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research . These . There are 15 older and 2 younger executives at Wave Life Sciences. Peter Kolchinsky, RA Capital's founder and managing partner, joins to talk about why so many of the policy ideas floated around drug-pricing are wrongheaded. Welcome back to Endpoints Weekly, your review of the weeks top biopharma headlines. $20M on February 16, 2023. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. On average, Peter trades about 366,737 units every 19 days since 2014. Hard work has helped him rise to the top. All Rights Reserved. Verified account Protected Tweets @; Suggested users This ground-breaking new book, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines (January 20, 2020), by Peter Kolchinsky, PhD, examines the healthcare landscape through the lens of the biotech social contract with America - the implicit agreement between the biopharmaceutical industry and American society - including the government's role in inventing . Peter Kolchinsky. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. Anna and Keri hope their husbands dont electrocute themselves in the process. In support of his arguments, he shared insights from government and industry professionals and cited facts and figures on the trajectory of the drug market. Words cant bring Christina Aguilera down but frown lines can. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. Stock quotes provided by InterActive Data. Jonathan McNeill who sold, In the last 16 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of, https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. Were not in a rush, Anna explained, and want to take some time to get to know the town. Warren Buffett has made it clear. The most active insiders traders include Capital Management, L.P.Ra , Capital Management, Llc Kol und Peter Kolchinsky. The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by Dr. Kolchinsky also leads RA Capitals engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . and bought an estimated value of $64.19M worth of shares. These are the three biggest challenges for innovators in large organizations and the three biggest enablers of success. May 27, 2022 (This is a long piece; click here to read it in Bionic Reading format, which may for some increase reading speed and comprehension. . Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Wallmine is a radically better financial terminal. So they invited their close friends Keri and Ben up for what they, Keri and Ben, long-time city dwellers, were, new dream and a substantial life-style change, One of my favorite paintings is from the Blue Horses, , and, of course, horses were what brought the couple to Woodstock. Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! Nominations are now open for a special report that will highlight the contributions of LGBTQ+ biopharma leaders.